ALLO- AND AUTOTRANSPLANTATION OF CAROTID ARTERY-A NEW MODEL OF CHRONIC GRAFT VESSEL DISEASE
| Autor: | Sabine Wehr, Robert P. Hof, Joanne Joergensen, Akiko Hof, Markus Rudin |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Neointima
Pathology medicine.medical_specialty medicine.medical_treatment Graft vs Host Disease Lumen (anatomy) Transplantation Autologous Transplantation Immunology In vivo Animals Transplantation Homologous Medicine Transplantation medicine.diagnostic_test business.industry Vascular disease Body Weight Rats Inbred Strains Magnetic resonance imaging Arteriosclerosis medicine.disease Magnetic Resonance Imaging Autotransplantation Rats Carotid Arteries medicine.anatomical_structure Rats Inbred Lew Postmortem Changes Cyclosporine business Artery |
| Zdroj: | Transplantation. 64:20-27 |
| ISSN: | 0041-1337 |
| DOI: | 10.1097/00007890-199707150-00005 |
| Popis: | BACKGROUND: Graft vessel disease is a special form of accelerated arteriosclerosis. Because immunological and nonimmunological factors can contribute to graft vessel disease, we developed a model that enables the study of both factors simultaneously. METHODS: A carotid artery was allografted from DA to Lewis rats, with the excised native artery autografted on the contralateral side. Five groups of six to seven rats were treated for 8 weeks with vehicle (placebo) or cyclosporine (CsA) (0.3, 1, 3, and 10 mg x kg(-1) x day(-1)), which was administered using subcutaneous osmotic minipumps. The carotid lumen area was estimated in vivo at 2, 4, and 8 weeks by magnetic resonance imaging (MRI); CsA blood levels were determined twice. Carotid neointimal thickening and medial and luminal area were measured with histological techniques. RESULTS: MRI showed bulging of the allografts but not autografts. Bulging disappeared over time with narrowing of the allograft lumina estimated by both MRI and histology. Histologically, vehicle-treated animals developed a massive neointima, which was inhibited in a dose-dependent manner by CsA. Autografts remained normal except for minimal subintimal thickening of two of four arteries in the group given the highest dose of CsA. Cellular rejection was detected in the allografts of all but the highest-dose group. The CsA blood levels were similar to those used in man at the two lower doses and about 10-fold higher at the highest dose. CONCLUSIONS: Subintimal thickening did not correlate with in vivo lumen size, a phenomenon that we have previously described for balloon catheter-induced lesions. CsA blood concentrations similar to those used in patients suppressed neointima formation in part, and 10-fold higher concentrations almost completely suppressed neointima formation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|